Skip to content
Mobidiag logo
Mobidiag
Enabling faster, more accessible molecular diagnostics
  • Home
  • Solutions
    • Respiratory Infections
    • Gastrointestinal Infections
    • Antimicrobial Resistance Management
    • Healthcare Associated Infections
    • Sepsis
  • Products
    • Coronavirus tests
    • Coronavirus solution
    • Novodiag® COVID-19
    • Amplidiag® COVID-19
    • Mobidiag - Novodiag
    • Novodiag® Solution (CE-IVD)
    • COVID-19
    • C. difficile
    • Bacterial GE+
    • CarbaR+
    • Stool Parasites
    • Mobidiag - Amplidiag
    • Amplidiag® Solution (CE-IVD)
    • COVID-19
    • H. pylori+ClariR
    • Bacterial GE
    • CarbaR+VRE
    • CarbaR+MCR
    • Stool Parasites
    • Viral GE
    • C. difficile+027
    • LifeSciences (RUO)
    • S7 Fusion Polymerase™
    • Amplidiag® Multiplex PCR Master Mix
  • News
    • News
    • Events
    • Blog
  • Literature
    • Publications
    • Posters
  • Company
    • About Us
    • Quality
    • Board of Directors
    • Management Team
    • Investors
    • Careers
  • Contact
    • Contact Us
    • Worldwide Distributors
  • Log in
  • Log in

News

ECCMID 2019, Amsterdam, Netherlands

May 1, 2019

Johanna Haiko, Tanja Holma, Jenni Antikainen, Anu Pätäri-Sampo; Molecular carbapenemase tests Eazyplex SuperBug Complete B, Novodiag CarbaR+, and Amplidiag CarbaR+MCR, provide high sensitivity in the detection of carbapenemase-positive bacteria
Learn more about Novodiag® CarbaR+ and Amplidiag® CarbaR+MCR

Share on: Share on FacebookShare on LinkedinShare on Twitter
Posted in: Posters

Post navigation

← Mobidiag to attend the 29th European Congress of Clinical Microbiology & Infectious Diseases in Amsterdam, the Netherlands
Mobidiag secures EUR 25 million from European Investment Bank →

Mobidiag Logo

Mobidiag (HQ)

Keilaranta 16 A
FIN-02150 Espoo
Finland

+358 10 5050 770
sales@mobidiag.com

Mobidiag France

172 rue de Charonne
Le Dorian B2
75011 Paris
France

+33 1 55 25 17 00
adv@mobidiag.com

Mobidiag UK

Aston Court, Kingsmead Business Park,
Frederick Place, High Wycombe
Buckinghamshire, HP11 1LA
UK
+44 (0) 333 305 7506
sales@mobidiag.com

Mobidiag Sweden

+358 10 5050 770
sales@mobidiag.com

Site map

  • Home
  • Solutions
    • Respiratory Infections
    • Gastrointestinal Infections
    • Antimicrobial Resistance Management
    • Healthcare Associated Infections
    • Sepsis
  • Products
    • Coronavirus solutions
    • Novodiag® Solution (CE-IVD)
      • COVID-19
        • Novodiag COVID-19
        • Amplidiag COVID-19
      • C. difficile
      • Bacterial GE+
      • CarbaR+
      • Stool Parasites
    • Amplidiag® Solution (CE-IVD)
      • COVID-19
      • H. pylori+ClariR
      • Viral GE
      • CarbaR+VRE
      • CarbaR+MCR
      • Stool Parasites
      • Bacterial GE
      • C. difficile+027
    • LifeSciences (RUO)
      • S7 Fusion Polymerase
      • Amplidiag® Multiplex PCR Master Mix
  • News
    • News
    • Events
    • Blog
  • Company
    • About Us
    • Quality
    • Management Team
    • Board of Directors
    • Investors
    • Careers
  • Literature
  • Contact
    • Contact Us
    • Worldwide Distributors
  • Client Portal
    • Login or Register
    • Edit My Profile

Search

Contact Us

Privacy Policy
Copyright © Mobidiag Ltd. All Rights Reserved. Learn more about our Privacy policy.
Website crafted by Design Reform.
Top
We use cookies on our website to improve the quality of your browsing experience. Information about the types of cookies we use is available from our Privacy Policy. We recommend that you read the provided information before making your selection. If you do decide not to approve of our use of cookies, some parts of the website may not function as well as if you choose to do so. Ok